Literature DB >> 9651866

Preparation and in vitro dissolution profile of dual polymer (Eudragit RS100 and RL100) microparticles of diltiazem hydrochloride.

S K Das1, N G Das.   

Abstract

A microparticulate dosage form for a highly soluble drug, diltiazem hydrochloride, was formulated with Eudragit RS100 and RL100 using a novel dual polymer technique. A mixture of diltiazem with Eudragit RS100 (low water permeability) in acetone was coacervated into soft polymer microdrops, following which a mixture of diltiazem and RL100 (high water permeability) was added to produce microparticles consisting of both polymers with diltiazem dispersed in the matrix. A second formulation was developed using the same method except using Eudragit RS100 for both steps. For a comparative study, diltiazem, Eudragit RS100 and RL100 were combined together in a single matrix and formulated into microparticles. In vitro drug release profiles using USP paddle dissolution apparatus 2 revealed that dual polymer matrix microparticles containing Eudragit RS100 in the inner and Eudragit RL100 in the outer core exhibit a suitable release profile with an initial release of the drug followed by a plateau level for the test period of 5 h. Differential scanning calorimetric analysis showed no interaction of the drug with the polymers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9651866     DOI: 10.3109/02652049809006871

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  9 in total

1.  Preparation and Characterization of pH-Independent Sustained-Release Tablets Containing Hot Melt Extruded Solid Dispersions of Clarithromycin : Tablets Containing Solid Dispersions of Clarithromycin.

Authors:  Qazi Amir Ijaz; Sumera Latif; Qurat-Ul-Ain Shoaib; Memoona Rashid; Muhammad Sohail Arshad; Amjad Hussain; Nadeem Irfan Bukhari; Sohail Riaz; Nasir Abbas
Journal:  AAPS PharmSciTech       Date:  2021-11-12       Impact factor: 3.246

2.  Design and In Vitro Evaluation of Eudragit-Based Extended Release Diltiazem Microspheres for Once- and Twice-Daily Administration: The Effect of Coating on Drug Release Behavior.

Authors:  Noushin Bolourchian; Maryam Bahjat
Journal:  Turk J Pharm Sci       Date:  2019-07-10

3.  Preparation and in vitro Evaluation of Ethylcellulose Coated Egg Albumin Microspheres of Diltiazem Hydrochloride.

Authors:  Tp Shailesh; Pd Vipul; Jk Girishbhai; Cj Manish
Journal:  J Young Pharm       Date:  2010-01

4.  Preparation and Determination of Drug-Polymer Interaction and In-vitro Release of Mefenamic Acid Microspheres Made of CelluloseAcetate Phthalate and/or Ethylcellulose Polymers.

Authors:  Mitra Jelvehgari; Davoud Hassanzadeh; Farhad Kiafar; Badir Delf Loveym; Sara Amiri
Journal:  Iran J Pharm Res       Date:  2011       Impact factor: 1.696

5.  Composite alginate hydrogel microparticulate delivery system of zidovudine hydrochloride based on counter ion induced aggregation.

Authors:  Harekrishna Roy; P Venkateswar Rao; Sanjay Kumar Panda; Asim Kumar Biswal; Kirti Ranjan Parida; Jharana Dash
Journal:  Int J Appl Basic Med Res       Date:  2014-09

6.  Development and statistical optimization of nefopam hydrochloride loaded nanospheres for neuropathic pain using Box-Behnken design.

Authors:  S Sukhbir; S Yashpal; A Sandeep
Journal:  Saudi Pharm J       Date:  2015-03-25       Impact factor: 4.330

7.  Maximizing the encapsulation efficiency and the bioavailability of controlled-release cetirizine microspheres using Draper-Lin small composite design.

Authors:  Khalid Mohamed El-Say
Journal:  Drug Des Devel Ther       Date:  2016-02-24       Impact factor: 4.162

8.  In-vitro and in-vivo evaluation of repaglinide loaded floating microspheres prepared from different viscosity grades of HPMC polymer.

Authors:  Megha Sharma; Seema Kohli; Agnimitra Dinda
Journal:  Saudi Pharm J       Date:  2015-02-27       Impact factor: 4.330

9.  Preparation and In Vitro-In Vivo Evaluation of Luteolin Loaded Gastroretentive Microsponge for the Eradication of Helicobacter pylori Infections.

Authors:  Mohammed Jafar; Mohammed Salahuddin; Mohd Sajjad Ahmad Khan; Yasir Alshehry; Nazar Radwan Alrwaili; Yazeed Ali Alzahrani; Syed Sarim Imam; Sultan Alshehri
Journal:  Pharmaceutics       Date:  2021-12-06       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.